Added to YB: 2024-09-27
Pitch date: 2024-09-25
TEM [neutral]
Tempus AI, Inc.
-6.02%
current return
Author Info
Two Natural Capital writes about markets, particularly focused on life sciences/biotech. Sign up for the newsletter.
Company Info
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician’s desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests.
Market Cap
$8.4B
Pitch Price
$50.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-57.12
P/E
-33.40
EV/Sales
7.05
Sector
Life Sciences Tools and Services
Category
growth
Tempus AI: A (Tentative) Short Thesis $tem
TEM (risky potential short): Oncology data leader, 531mm rev '23, 32% YoY growth. AI hype but only 1% AI rev. Mainly cancer diagnostics (363mm, 48% margin). Data business serves 19/20 top pharma. 10x EV/2025e sales. Bull: data asset for future AI. Bear: AI revenue far off, reimbursement issues. Short idea but timing risky due to AI hype.
Read full article (7 min)